Observational studyTechnology in cancer research & treatment

Neutrophil-to-Lymphocyte Ratio and Early Tumor Shrinkage as Predictive Biomarkers in Unresectable Hepatocellular Carcinoma Patients Treated With Lenvatinib, PD-1 Inhibitors, in Combination With TACE.

Shuping Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.